Amphenol Corporation announced its third quarter 2026 financial results featuring sales of $10.2 billion and GAAP diluted EPS of $0.79. The company also approved a 20% quarterly dividend increase to $0.15 per share and authorized a new three-year $4.0 billion stock repurchase program starting January 1, 2027.
Third quarter sales reached $10.2 billion, representing a 65% increase year-over-year.
The quarterly dividend was increased by 20% to $0.15 per share, effective in the fourth quarter of 2026.
A new three-year open market stock repurchase program of up to $4.0 billion was authorized beginning January 1, 2027.
Fourth quarter 2026 sales are expected to be between $10.3 billion and $10.5 billion.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Amphenol's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$23.09B
+51.7%
$3.34
+74.0%
18.5%
FY2024
$15.22B
+21.3%
$1.92
+23.9%
15.9%
FY2023
$12.55B
-0.5%
$1.55
+1.3%
15.4%
FY2022
$12.62B
+16.1%
$1.53
-39.8%
15.1%
FY2021
$10.88B
+26.5%
$2.54
+29.6%
14.6%
Frequently asked questions
When is Amphenol's next earnings date?
Amphenol has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did Amphenol earn last quarter?
For the quarter ended Sep 2026, Amphenol reported diluted EPS of $0.79 (+61.2% year over year) on revenue of $10.23B (+65.1%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.